Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 16/20 | 1.00 |
| ▸ | KDR | P35968 | 1/20 | 0.63 |
| ▸ | SRC | P12931 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7987501 | 0.99 | FGFR1 (0.97) | FGFR1KDRSRC | |
| SCHEMBL20603962 | 0.86 | FGFR1 (0.75) | FGFR1KDRSRC | |
| SCHEMBL8006768 | 0.85 | FGFR1 (1.00) | FGFR1KDRSRC | |
| SCHEMBL7990502 | 0.85 | FGFR1 (0.73) | FGFR1KDRSRC | |
| Hydrochloric Acid SCHEMBL7989899 | 0.84 | FGFR1 (0.97) | FGFR1KDRSRC | |
| SCHEMBL7986395 | 0.82 | FGFR1 (0.80) | FGFR1KDRSRC | |
| Hydrochloric Acid SCHEMBL7975633 | 0.81 | FGFR1 (0.78) | FGFR1KDRSRC | |
| SCHEMBL7993339 | 0.80 | FGFR1 (1.00) | FGFR1KDRSRC | |
| SCHEMBL7992992 | 0.80 | FGFR1 (1.00) | FGFR1KDRSRC | |
| SCHEMBL15213070 | 0.80 | FGFR1 (0.67) | FGFR1KDRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218388-B1 | THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE | WARNER-LAMBERT COMPANY | 2001-04-17 | — | — | US | disclosed |
| US-6207686-B1 | FOR THERAPY OF HYPERTENSION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| US-5990146-A | TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1996015109-A1 | ENDOTHELIN ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-05-23 | — | — | WO | disclosed |